Thursday Feb 9 | Sys-Con Media
Rock Creek Pharmaceuticals Announces Initiation of Second Multi-Site...
Rock Creek Pharmaceuticals Announces Initiation of Second Multi-Site Clinical Trial; Protocol to Study an Anatabloc Formulation and Thyroid Health GLEN ALLEN, VA -- -- 02/09/12 -- Star Scientific subsidiary, Rock Creek Pharmaceuticals, is pleased to announce IRB approval, and successful identification and selection of five clinical sites in Texas, ... (more)
Thursday Feb 9 | Wall St. Cheat Sheet
Investors Buy These Company Shares Ahead of Earnings
Lorillard, Inc. A will unveil its latest earnings on Thursday, February 9, 2012.A The average estimate of analysts is for profit of $1.96 per share, a rise of 12.6% from the company's actual earnings for the same quarter a year ago.
GNC and Star Scientific , Inc.'s Rock Creek Pharmaceuticals Partner ...
GNC and Star Scientific , Inc. 's Rock Creek Pharmaceuticals Partner to Offer Anatabloc Through GNC's Online Retail Platform Rock Creek Pharmaceuticals, Inc., a subsidiary of Star Scientific, Inc.
Rock Creek Pharmaceuticals Reports First Clinical Trial Showing...
Note: Anatabine blood levels were not zero for non-users due to the presence of anatabine in tobacco Rock Creek Pharmaceuticals, Inc., a subsidiary of Star Scientific, Inc.
Altria Shares Fall as NextEra Energy Climbs After Shareholders Digest Earnings
Altria Group Inc. A reported its results for the fourth quarter.A Net income for Altria Group Inc.
The top after-market NASDAQ gainers Thursday were: Cepheid, Informatica Corp, QLogic Corp, Illumina, Star Scientific, Dreamworks Animation SKG, Seagate Technology, Sigma-Aldrich, Silicon Motion Technology and Seattle Genetics.
UPDATE 1-Star Scientific, Reynolds American to explore patent settlement
Electronic cigarettes maker Star Scientific Inc said a federal court referred its patent infringement case with a unit of Reynolds American Inc to a magistrate judge for possible settlement.
Also on Topix